This journal publishes research on the clinical evaluation of novel cancer therapies, including chemotherapy combinations, targeted therapies, and immunotherapies. Studies focus on assessing the efficacy and safety of these treatments across various cancer types, such as breast cancer, lung cancer, colorectal cancer, and prostate cancer. The research often involves randomized controlled trials to compare new treatment regimens against standard care or placebo, with endpoints including overall survival, progression-free survival, and response rates.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Cancer ResearchQ1
Medicine (miscellaneous)Q1
OncologyQ1
Subject Classification
Web of Science Categories
Oncology
Scopus Categories
Cancer ResearchOncologyMedicine (miscellaneous)
Research Topics (OpenAlex)
Lung Cancer Treatments and MutationsCancer Treatment and PharmacologyCancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesCancer Immunotherapy and BiomarkersProstate Cancer Treatment and ResearchGastric Cancer Management and OutcomesLung Cancer Research StudiesBreast Cancer Treatment StudiesEconomic and Financial Impacts of Cancer